Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's DiseasePaul B Rosenberg, Krista L Lanctôt, Nathan Herrmann, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)Lea T Drye, Roberta W Scherer, Krista L Lanctôt, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 3, 2007
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed dosesJacobo E Mintzer, Larry E Tune, Christopher D Breder, et al.Current Drug Targets|July 24, 2004
Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factorsKumar Sambamurti, Ann-Charlotte Granholm, Mark S Kindy, et al.The Journal of Clinical Psychiatry|September 12, 2013
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trialPaul B Rosenberg, Krista L Lanctôt, Lea T Drye, et al.Dementia and Geriatric Cognitive Disorders|March 12, 2009
Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical coreDavid L Bachman, Marilyn Stuckey, Myla Ebeling, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.International Psychogeriatrics|October 31, 2013
Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trialKrista L Lanctôt, Sarah A Chau, Nathan Herrmann, et al.International Journal of Geriatric Psychiatry|January 22, 2005
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'Paul B Rosenberg, Chiadi U Onyike, Ira R Katz, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.Pageof 5